FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation
For Immediate Release: January 11, 2026 The U.S. Food and Drug Administration today announced it is sharing information about the agency’s flexible approach to overseeing chemistry, manufacturing and control (CMC) requirements for cell and gene therapies ( …